ofloxacin has been researched along with Sinus Infections in 41 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levofloxacin 750 mg for 5 days represents a safe and effective treatment regimen for acute bacterial sinusitis." | 9.12 | A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis. ( Anon, J; Kahn, J; Khashab, M; Paglia, M; Poole, M; Xiang, J, 2006) |
| "Treatment guidelines for acute bacterial rhinosinusitis (ABRS) recommend 10 to 14 days of therapy with high-dose amoxicillin, amoxicillin/clavulanate, cefdinir, cefpodoxime, cefuroxime, a macrolide, or a newer fluoroquinolone, among other agents." | 9.11 | Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study. ( Busman, TA; Henry, DC; Kapral, D; Paris, MM, 2004) |
| "The authors had for aim to evaluate the efficacy and tolerance of oral levofloxacin (500 mg once a day during ten days), as a treatment for acute bacterial sinusitis at risk for complications in adult patients." | 9.11 | [Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications]. ( Gehanno, P; Pessey, JJ; Serrano, E, 2005) |
| "We previously reported that a 6-month low-dose course of ofloxacin combined with long-term low-dose erythromycin therapy (EM therapy) was superior to EM therapy alone for sinobronchial syndrome (SBS), especially during the initial 2 months of treatment." | 9.10 | Addition of a 2-month low-dose course of levofloxacin to long-term erythromycin therapy in sinobronchial syndrome. ( Fujimura, M; Mizuguchi, M; Mizuhashi, K; Nakatsumi, Y; Sasaki, S; Yasui, M, 2002) |
| "Levofloxacin is effective for the treatment of sinusitis in adults and pay attention to the course of treatment for raising the efficacy of treatment." | 9.09 | [Comparison of the effectiveness of levofloxacin and cefuroxime for the treatment of sinusitis]. ( Li, XP; Qin, ZM; Tan, QL; Yin, AF; Zheng, RH; Zhou, YY; Zhu, L, 2000) |
| "In this comparative trial, outpatients with acute sinusitis were randomly assigned to receive levofloxacin (500 mg orally once daily) or amoxicillin-clavulanate (500/125 mg orally 3 times daily) for 10 to 14 days." | 9.09 | Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults. ( Adelglass, J; Campbell, T; DeAbate, CA; Fowler, CL; LoCocco, J; McElvaine, P, 1999) |
| "It has been established that long-term low-dose erythromycin therapy (EM therapy) is very effective for sinobronchial syndrome, a common condition in Japan characterized by chronic upper and lower airway inflammation." | 9.08 | Additive effect of continuous low-dose ofloxacin on erythromycin therapy for sinobronchial syndrome. ( Fujimura, M; Ishiura, Y; Matsuda, T; Nakatsumi, Y; Nomura, M; Saito, M; Shibata, K, 1995) |
| "To evaluate the efficacy and safety of levofloxacin (500 mg orally once daily for 10 to 14 days) in treating adult outpatients with acute bacterial sinusitis." | 9.08 | Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults. ( Anthony, KE; Fowler, CL; Kim, SS; Kopp, EJ; LoCoco, JM; Sydnor, TA, 1998) |
| "Adult patients with acute sinusitis (n = 236) were randomized in a double-blind study to levofloxacin 500 mg orally once daily (n = 119) or clarithromycin 500 mg orally twice daily (n = 117) for 10-14 days." | 9.08 | Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group. ( Anstey, RJ; Lasko, B; Lau, CY; Martel, A; Reddington, JL; Saint-Pierre, C, 1998) |
| "A multicentric study was conducted to evaluate the clinical efficacy and tolerance of ofloxacin in the treatment of chronic sinusitis and chronic otitis (CSOM) in outpatients." | 9.07 | Effectiveness and safety of ofloxacin in chronic otitis media and chronic sinusitis in adult outpatients. ( Cohen, B; Gehanno, P, 1993) |
| "The present study compared ofloxacin and erythromycin in a double-blind study with parallel groups for clinical efficacy and the number and severity of adverse reactions in patients treated in general practice for acute or chronic sinusitis." | 9.07 | Antibiotic treatment of sinusitis in general practice. A double-blind study comparing ofloxacin and erythromycin. ( Egede, F; Husfeldt, P; Nielsen, PB, 1993) |
| " The objective is to determine the effect of application of topical ofloxacin on nasal and sinus mucosa in patients with proven existence of bacterial biofilms and persistent chronic sinusitis after FESS." | 7.81 | Effect of topical ofloxacin on bacterial biofilms in refractory post-sinus surgery rhino-sinusitis. ( Ezzat, WF; Fawaz, SA; Hamdy, TA; Rabie, H; Shokry, YA, 2015) |
| "A previous study found that a single 2-g dose of azithromycin extended release (AZ-ER) was as efficacious as 10 days of levofloxacin (LFX) 500 mg QD in adults with acute bacterial rhinosinusitis (ABRS)." | 7.74 | Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial. ( de Caprariis, PJ; Marple, BF; Reisman, A; Roberts, CS, 2007) |
| "The PharMetrics Patient-Centric claims database was searched over a 3-year period for episodes of acute rhinosinusitis treated within 5 days with moxifloxacin or levofloxacin." | 7.73 | Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: a retrospective database analysis of treatment duration, outcomes, and charges. ( Friedman, HS; Keating, KN; Perfetto, EM, 2006) |
| "Levofloxacin 750 mg for 5 days represents a safe and effective treatment regimen for acute bacterial sinusitis." | 5.12 | A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis. ( Anon, J; Kahn, J; Khashab, M; Paglia, M; Poole, M; Xiang, J, 2006) |
| "Treatment guidelines for acute bacterial rhinosinusitis (ABRS) recommend 10 to 14 days of therapy with high-dose amoxicillin, amoxicillin/clavulanate, cefdinir, cefpodoxime, cefuroxime, a macrolide, or a newer fluoroquinolone, among other agents." | 5.11 | Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study. ( Busman, TA; Henry, DC; Kapral, D; Paris, MM, 2004) |
| "The authors had for aim to evaluate the efficacy and tolerance of oral levofloxacin (500 mg once a day during ten days), as a treatment for acute bacterial sinusitis at risk for complications in adult patients." | 5.11 | [Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications]. ( Gehanno, P; Pessey, JJ; Serrano, E, 2005) |
| "We previously reported that a 6-month low-dose course of ofloxacin combined with long-term low-dose erythromycin therapy (EM therapy) was superior to EM therapy alone for sinobronchial syndrome (SBS), especially during the initial 2 months of treatment." | 5.10 | Addition of a 2-month low-dose course of levofloxacin to long-term erythromycin therapy in sinobronchial syndrome. ( Fujimura, M; Mizuguchi, M; Mizuhashi, K; Nakatsumi, Y; Sasaki, S; Yasui, M, 2002) |
| "Levofloxacin is effective for the treatment of sinusitis in adults and pay attention to the course of treatment for raising the efficacy of treatment." | 5.09 | [Comparison of the effectiveness of levofloxacin and cefuroxime for the treatment of sinusitis]. ( Li, XP; Qin, ZM; Tan, QL; Yin, AF; Zheng, RH; Zhou, YY; Zhu, L, 2000) |
| "In this comparative trial, outpatients with acute sinusitis were randomly assigned to receive levofloxacin (500 mg orally once daily) or amoxicillin-clavulanate (500/125 mg orally 3 times daily) for 10 to 14 days." | 5.09 | Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults. ( Adelglass, J; Campbell, T; DeAbate, CA; Fowler, CL; LoCocco, J; McElvaine, P, 1999) |
| "It has been established that long-term low-dose erythromycin therapy (EM therapy) is very effective for sinobronchial syndrome, a common condition in Japan characterized by chronic upper and lower airway inflammation." | 5.08 | Additive effect of continuous low-dose ofloxacin on erythromycin therapy for sinobronchial syndrome. ( Fujimura, M; Ishiura, Y; Matsuda, T; Nakatsumi, Y; Nomura, M; Saito, M; Shibata, K, 1995) |
| "To evaluate the efficacy and safety of levofloxacin (500 mg orally once daily for 10 to 14 days) in treating adult outpatients with acute bacterial sinusitis." | 5.08 | Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults. ( Anthony, KE; Fowler, CL; Kim, SS; Kopp, EJ; LoCoco, JM; Sydnor, TA, 1998) |
| "Adult patients with acute sinusitis (n = 236) were randomized in a double-blind study to levofloxacin 500 mg orally once daily (n = 119) or clarithromycin 500 mg orally twice daily (n = 117) for 10-14 days." | 5.08 | Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group. ( Anstey, RJ; Lasko, B; Lau, CY; Martel, A; Reddington, JL; Saint-Pierre, C, 1998) |
| "A multicentric study was conducted to evaluate the clinical efficacy and tolerance of ofloxacin in the treatment of chronic sinusitis and chronic otitis (CSOM) in outpatients." | 5.07 | Effectiveness and safety of ofloxacin in chronic otitis media and chronic sinusitis in adult outpatients. ( Cohen, B; Gehanno, P, 1993) |
| "The present study compared ofloxacin and erythromycin in a double-blind study with parallel groups for clinical efficacy and the number and severity of adverse reactions in patients treated in general practice for acute or chronic sinusitis." | 5.07 | Antibiotic treatment of sinusitis in general practice. A double-blind study comparing ofloxacin and erythromycin. ( Egede, F; Husfeldt, P; Nielsen, PB, 1993) |
| "Levofloxacin and sparfloxacin are active against pathogens frequently involved in community-acquired upper and lower respiratory tract infections, including Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Mycoplasma pneumoniae, Legionella pneumophila, and Chlamydia pneumoniae." | 4.80 | Levofloxacin and sparfloxacin: new quinolone antibiotics. ( Chuck, SK; Jung, R; Martin, SJ; Messick, CR; Meyer, JM; Pendland, SL, 1998) |
| " The objective is to determine the effect of application of topical ofloxacin on nasal and sinus mucosa in patients with proven existence of bacterial biofilms and persistent chronic sinusitis after FESS." | 3.81 | Effect of topical ofloxacin on bacterial biofilms in refractory post-sinus surgery rhino-sinusitis. ( Ezzat, WF; Fawaz, SA; Hamdy, TA; Rabie, H; Shokry, YA, 2015) |
| "Levofloxacin (levogyre form of ofloxacin) has been approved for the treatment of acute and chronic sinusitis, pneumonia, and exacerbation of bronchopulmonary diseases, urinary, digestive and biliary infections in adults." | 3.76 | [Levofloxacin in children]. ( Cohen, R; Grimprel, E, 2010) |
| "A previous study found that a single 2-g dose of azithromycin extended release (AZ-ER) was as efficacious as 10 days of levofloxacin (LFX) 500 mg QD in adults with acute bacterial rhinosinusitis (ABRS)." | 3.74 | Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial. ( de Caprariis, PJ; Marple, BF; Reisman, A; Roberts, CS, 2007) |
| "The PharMetrics Patient-Centric claims database was searched over a 3-year period for episodes of acute rhinosinusitis treated within 5 days with moxifloxacin or levofloxacin." | 3.73 | Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: a retrospective database analysis of treatment duration, outcomes, and charges. ( Friedman, HS; Keating, KN; Perfetto, EM, 2006) |
| "Ofloxacin was used at a dosage of 300 mg to 800 mg daily for three to 20 days in 206 cases of various infectious diseases in the otorhinolaryngological field such as otitis media, external otitis, paranasal sinusitis, tonsillitis and pharyngolaryngitis." | 2.66 | Clinical efficacy of ofloxacin in the treatment of otorhinolaryngological infections. ( Baba, S, 1986) |
| "We suspected drug-induced pneumonitis, because her history of fever seemed to be related to drug administration for sinusitis." | 1.33 | [A case of drug-induced pneumonitis due to levofloxacin and kampo medicine]. ( Arakaki, N; Shimoji, T; Tamaki, K; Tohyama, M, 2006) |
| "Sinusitis was induced in six rabbits in order to evaluate its influence on the proliferation of cells in the olfactory epithelium compared with the respiratory epithelium during conservative antibiotic therapy." | 1.31 | Uptake of BrdU in olfactory and respiratory epithelium of rabbits with experimental sinusitis. ( Egawa, M; Kurono, Y; Matsune, S; Ohyama, M, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.44) | 18.7374 |
| 1990's | 11 (26.83) | 18.2507 |
| 2000's | 22 (53.66) | 29.6817 |
| 2010's | 7 (17.07) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ezzat, WF | 1 |
| Fawaz, SA | 1 |
| Rabie, H | 1 |
| Hamdy, TA | 1 |
| Shokry, YA | 1 |
| El-Hennawi, DM | 1 |
| Ahmed, MR | 2 |
| Farid, AM | 1 |
| Al Murtadah, AM | 1 |
| Bakshi, SS | 2 |
| Videler, WJ | 1 |
| van Drunen, CM | 1 |
| Reitsma, JB | 1 |
| Fokkens, WJ | 1 |
| Guss, J | 1 |
| Abuzeid, WM | 1 |
| Doghramji, L | 1 |
| Edelstein, PH | 1 |
| Chiu, AG | 1 |
| Hekiert, AM | 1 |
| Cohen, MB | 1 |
| Montone, KT | 1 |
| Palmer, JN | 1 |
| Govindaraj, S | 1 |
| Grimprel, E | 1 |
| Cohen, R | 1 |
| Pessey, JJ | 2 |
| Fujimura, M | 3 |
| Mizuguchi, M | 1 |
| Nakatsumi, Y | 3 |
| Mizuhashi, K | 1 |
| Sasaki, S | 1 |
| Yasui, M | 1 |
| Iakovlev, SV | 1 |
| Iakovlev, VP | 1 |
| Kriukov, AI | 1 |
| Sedinkin, AA | 1 |
| Aleksanian, TA | 1 |
| Li, XP | 1 |
| Qin, ZM | 1 |
| Zheng, RH | 1 |
| Tan, QL | 1 |
| Zhou, YY | 1 |
| Zhu, L | 1 |
| Yin, AF | 1 |
| Henry, DC | 1 |
| Kapral, D | 1 |
| Busman, TA | 1 |
| Paris, MM | 1 |
| Anon, JB | 1 |
| Gehanno, P | 2 |
| Serrano, E | 1 |
| Poole, M | 1 |
| Anon, J | 1 |
| Paglia, M | 1 |
| Xiang, J | 1 |
| Khashab, M | 1 |
| Kahn, J | 1 |
| Keating, KN | 1 |
| Friedman, HS | 1 |
| Perfetto, EM | 1 |
| Hadley, JA | 1 |
| De Benedetto, M | 1 |
| Salerni, L | 1 |
| De Benedetto, L | 1 |
| Passali, GC | 1 |
| Passali, D | 1 |
| Pea, F | 1 |
| Marioni, G | 2 |
| Pavan, F | 1 |
| Staffieri, C | 2 |
| Bottin, R | 1 |
| Staffieri, A | 2 |
| Furlanut, M | 1 |
| Rinaldi, R | 1 |
| Ottaviano, G | 1 |
| Marchese-Ragona, R | 1 |
| Giacomelli, L | 1 |
| Ferraro, SM | 1 |
| Tohyama, M | 1 |
| Arakaki, N | 1 |
| Tamaki, K | 1 |
| Shimoji, T | 1 |
| Ivanov, DV | 1 |
| Budanov, SV | 1 |
| Marple, BF | 1 |
| Roberts, CS | 1 |
| de Caprariis, PJ | 1 |
| Reisman, A | 1 |
| Cohen, B | 1 |
| Husfeldt, P | 1 |
| Egede, F | 1 |
| Nielsen, PB | 1 |
| Gaillot, O | 1 |
| Berche, P | 1 |
| Ishiura, Y | 2 |
| Saito, M | 2 |
| Shibata, K | 2 |
| Nomura, M | 2 |
| Matsuda, T | 2 |
| Martin, SJ | 1 |
| Meyer, JM | 1 |
| Chuck, SK | 1 |
| Jung, R | 1 |
| Messick, CR | 1 |
| Pendland, SL | 1 |
| Sydnor, TA | 1 |
| Kopp, EJ | 1 |
| Anthony, KE | 1 |
| LoCoco, JM | 1 |
| Kim, SS | 1 |
| Fowler, CL | 2 |
| Adelglass, J | 1 |
| DeAbate, CA | 1 |
| McElvaine, P | 1 |
| LoCocco, J | 1 |
| Campbell, T | 1 |
| Lasko, B | 1 |
| Lau, CY | 1 |
| Saint-Pierre, C | 1 |
| Reddington, JL | 1 |
| Martel, A | 1 |
| Anstey, RJ | 1 |
| Ramos, P | 1 |
| Hueto, J | 1 |
| El'kun, GB | 1 |
| Douadi, Y | 1 |
| Lescure, X | 1 |
| Schmit, JL | 1 |
| Matsune, S | 1 |
| Egawa, M | 1 |
| Ohyama, M | 1 |
| Kurono, Y | 1 |
| Scheen, AJ | 1 |
| Baba, S | 1 |
7 reviews available for ofloxacin and Sinus Infections
| Article | Year |
|---|---|
[Update on levofloxacin in the management of acute sinusitis with risk of complications].
Topics: Abscess; Acute Disease; Anti-Infective Agents; Cellulitis; Clinical Trials as Topic; Disease Progres | 2002 |
[Levofloxacin in the treatment of respiratory infections].
Topics: Acute Disease; Anti-Infective Agents; Bronchitis, Chronic; Clinical Trials as Topic; Drug Resistance | 2002 |
Current management of acute bacterial rhinosinusitis and the role of moxifloxacin.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Clinical Trials as Topic; Drug Resistanc | 2005 |
[Rhinosinusitis: etiopathogenesis and antimicrobial therapy, an update].
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Aza Compounds; Bacteria | 2006 |
[Levofloxacin and other antibacterial drugs].
Topics: Anti-Bacterial Agents; Bacterial Infections; Dermatitis; Dosage Forms; Humans; Levofloxacin; Ofloxac | 2006 |
Levofloxacin and sparfloxacin: new quinolone antibiotics.
Topics: Absorption; Anti-Infective Agents; Bronchitis; Drug Interactions; Drug Resistance, Microbial; Fluoro | 1998 |
[Usefulness of levofloxacin in sinusitis].
Topics: Anti-Infective Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Humans; Levofloxacin; O | 1999 |
16 trials available for ofloxacin and Sinus Infections
| Article | Year |
|---|---|
Comparative study of the efficacy of topical steroid and antibiotic combination therapy versus oral antibiotic alone when treating acute rhinosinusitis.
Topics: Administration, Intranasal; Administration, Oral; Adolescent; Adult; Amoxicillin; Anti-Bacterial Age | 2015 |
Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacitracin; Chron | 2008 |
Addition of a 2-month low-dose course of levofloxacin to long-term erythromycin therapy in sinobronchial syndrome.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bronchiolitis; Bronchitis; Drug Therapy, Combina | 2002 |
[Comparison of the effectiveness of levofloxacin and cefuroxime for the treatment of sinusitis].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cefuroxime; Drug Administrati | 2000 |
Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Cefdinir; Cephalosporins; Double-Blind Method; Fe | 2004 |
[Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications].
Topics: Acute Disease; Adolescent; Adult; Africa, Southern; Aged; Bacterial Infections; Female; France; Haem | 2005 |
A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Double-Blind Me | 2006 |
Effectiveness and safety of ofloxacin in chronic otitis media and chronic sinusitis in adult outpatients.
Topics: Administration, Oral; Adult; Ambulatory Care; Bacterial Infections; Chronic Disease; Humans; Ofloxac | 1993 |
Antibiotic treatment of sinusitis in general practice. A double-blind study comparing ofloxacin and erythromycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Double-Blind Method; Erythromycin; Fami | 1993 |
Additive effect of continuous low dose ofloxacin on erythromycin therapy for sinobronchial syndrome.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bronchitis; Drug Thera | 1995 |
Additive effect of continuous low-dose ofloxacin on erythromycin therapy for sinobronchial syndrome.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Carbocysteine; Drug Administratio | 1995 |
Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults.
Topics: Acute Disease; Adult; Anti-Infective Agents; Bacterial Infections; Exudates and Transudates; Female; | 1998 |
Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Am | 1999 |
Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agen | 1998 |
[Effectiveness of maxaquin and tarivid in combined therapy of patients with chronic sinusitis].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Antitubercular Agents; Chronic Disease; Drug Therapy | 1999 |
Clinical efficacy of ofloxacin in the treatment of otorhinolaryngological infections.
Topics: Anti-Infective Agents; Bacterial Infections; Clinical Trials as Topic; Humans; Laryngitis; Ofloxacin | 1986 |
18 other studies available for ofloxacin and Sinus Infections
| Article | Year |
|---|---|
Effect of topical ofloxacin on bacterial biofilms in refractory post-sinus surgery rhino-sinusitis.
Topics: Administration, Intranasal; Administration, Topical; Adult; Anti-Bacterial Agents; Biofilms; Case-Co | 2015 |
Comparative study of the efficacy of topical steroid and antibiotic combination therapy versus oral antibiotic alone when treating acute rhinosinusitis.
Topics: Amoxicillin; Anti-Bacterial Agents; Dexamethasone; Female; Glucocorticoids; Humans; Male; Ofloxacin; | 2015 |
Comment on: Effect of topical ofloxacin on bacterial biofilms in refractory post-sinus surgery rhino-sinusitis.
Topics: Biofilms; Chronic Disease; Humans; Nose; Ofloxacin; Paranasal Sinuses; Rhinitis; Sinusitis | 2016 |
Authors’ reply.
Topics: Amoxicillin; Anti-Bacterial Agents; Dexamethasone; Female; Glucocorticoids; Humans; Male; Ofloxacin; | 2015 |
Fluoroquinolone-resistant Pseudomonas aeruginosa in chronic rhinosinusitis.
Topics: Anti-Bacterial Agents; Chronic Disease; Ciprofloxacin; Comorbidity; Drug Resistance, Bacterial; Fluo | 2009 |
Ecthyma gangrenosum mimicking acute invasive fungal sinusitis in an immunocompromised patient.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Diagnosis, Differential; Ecthyma; Humans; Immunocompromise | 2010 |
[Levofloxacin in children].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Child; Community-Acquired Infections; Humans; Le | 2010 |
[Therapeutic and diagnostic policy in acute sinusitis].
Topics: Acute Disease; Adult; Algorithms; Anti-Bacterial Agents; Bacteria; Child; Diagnosis, Differential; H | 2002 |
Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: a retrospective database analysis of treatment duration, outcomes, and charges.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Aza Compounds; Database Management Systems; Female; Flu | 2006 |
Value of short-course antimicrobial therapy in acute bacterial rhinosinusitis.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Dose-Response Relat | 2005 |
Penetration of levofloxacin into paranasal sinuses mucosa of patients with chronic rhinosinusitis after a single 500 mg oral dose.
Topics: Adult; Aged; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Chronic Disease; Female; H | 2007 |
Burkholderia cepacia complex nasal isolation in immunocompetent patients with sinonasal polyposis not associated with cystic fibrosis.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Burkholderi | 2007 |
[A case of drug-induced pneumonitis due to levofloxacin and kampo medicine].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drugs, Chinese Herbal; Female; Humans; Levofloxacin; Medici | 2006 |
Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Dela | 2007 |
In vitro susceptibility to ciprofloxacin of bacterial strains isolated from chronic otitis media and chronic sinusitis.
Topics: Adult; Anti-Infective Agents; Bacteria; Chronic Disease; Ciprofloxacin; Drug Resistance, Microbial; | 1995 |
[A new antibiotic: levofloxacine].
Topics: Anti-Infective Agents; Bronchitis; Community-Acquired Infections; Humans; Ofloxacin; Pneumonia; Sinu | 2000 |
Uptake of BrdU in olfactory and respiratory epithelium of rabbits with experimental sinusitis.
Topics: Animals; Anti-Infective Agents; Bromodeoxyuridine; Cell Division; Immunohistochemistry; Ofloxacin; O | 2000 |
[Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)].
Topics: Acute Disease; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacterial Infections; Bronchit | 2000 |